financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lifts Opinion On Mccormick & Company, Incorporated To Buy From Hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lifts Opinion On Mccormick & Company, Incorporated To Buy From Hold
Mar 26, 2024 8:35 AM

11:05 AM EDT, 03/26/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target by $12 to $85, 27x our FY 25 (Nov.) EPS of $3.16 (up from $2.96; FY 24 up to $2.88 from $2.81) vs. the 30x five-year average forward P/E. FQ1 (Feb-Q) adj-EPS of $0.63 (+7% Y/Y) beat by $0.06 on revenues of $1,603M (+2% Y/Y), $51M above consensus. MKC saw a sequential improvement in volume sales (-1% Y/Y vs. -3% Y/Y in FQ4), which we expect will continue this year, especially if MKC regains some of the lost distribution it experienced over the last few years. MKC is also investing in marketing and innovation and looking to narrow price gaps to store brands. Gross margins grew 140 bps Y/Y to 37.4%, but due to SG&A de-leverage (from higher marketing), operating margins only grew 30 bps Y/Y to 14.8%. We should see stronger margins in F2H 24. MKC kept its guidance unchanged, but will likely raise it next quarter, in our opinion. We believe MKC is on track to return to double-digit EPS growth next fiscal year (FY 25), as this fiscal year (FY 24) is expected to be a heavy investment year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis
Oct 28, 2025
02:30 AM EDT, 10/29/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raised our target price to USD126 (from USD121) and our EPAS estimates to USD8.85 (from USD8.58) for 2025 and to USD9.00 (from USD8.90) for 2026, mainly to account for...
Research Alert: CFRA Keeps Buy Opinion On Shares Of A. O. Smith Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of A. O. Smith Corporation
Oct 28, 2025
12:50 AM EDT, 10/29/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month price target by $2 to $90 on a forward P/E of 20.5x our 2026 EPS estimate of $4.38 (up by $0.08), above the five-year forward average...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Globe Life Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Globe Life Inc.
Oct 28, 2025
02:35 AM EDT, 10/29/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price of $155, valuing GL shares at 9.6x our newly initiated 2027 operating EPS estimate of $16.20 and at 10.3x our 2026 EPS estimate of...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Hubbell Incorporated
Research Alert: CFRA Keeps Buy Opinion On Shares Of Hubbell Incorporated
Oct 28, 2025
01:55 AM EDT, 10/29/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $515 from $475, valuing shares at 26x our 2026 EPS outlook of $19.80 (up from $19.14; 2025 EPS raised to $18.40 from $17.65). HUBB...
Copyright 2023-2026 - www.financetom.com All Rights Reserved